Provided by Tiger Trade Technology Pte. Ltd.

Zentalis Pharmaceuticals, LLC

3.11
+0.03000.97%
Post-market: 3.240.1300+4.18%19:50 EDT
Volume:1.26M
Turnover:3.91M
Market Cap:294.43M
PE:-1.59
High:3.18
Open:3.07
Low:2.99
Close:3.08
52wk High:6.95
52wk Low:1.21
Shares:94.67M
Float Shares:75.29M
Volume Ratio:1.20
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9591
EPS(LYR):-1.9100
ROE:-66.75%
ROA:-33.15%
PB:2.05
PE(LYR):-1.63

Loading ...

Zentalis Pharmaceuticals, Inc. : William Blair Initiates Coverage with Outperform Rating

THOMSON REUTERS
·
Sep 16

William Blair Initiates Zentalis Pharmaceuticals at Outperform

MT Newswires Live
·
Sep 16

Zentalis initiated with an Outperform at William Blair

TIPRANKS
·
Sep 16

Zentalis Pharmaceuticals to Present at Morgan Stanley Global Healthcare Investor Conference

Reuters
·
Sep 03

Zentalis Grants 269,000 Inducement Stock Options to Four New Hires at $3.71 Each

Reuters
·
Sep 02

Zentalis Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 02

Walters Group Reports Purchase of 4,335,000 Zentalis Shares for $15.17 Million

Reuters
·
Aug 20

Zentalis Pharmaceuticals Closes Offering of Common Shares

MT Newswires Live
·
Aug 18

Zentalis Closes 26,450,000-Share Public Offering at $3.5 Per Share, Raises $92.6 Million Gross

Reuters
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 15

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14

Zentalis Pharmaceuticals Prices $80.5 Million Offering to Fund Clinical Pipeline

MT Newswires Live
·
Aug 14

Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering

Reuters
·
Aug 14

Zentalis Prices 23 Million-Share Follow-on Offering at $3.5 Per Share

Reuters
·
Aug 14

Zentalis Pharmaceuticals - Prices Public Offering of 23 Mln Shares at $3.50 Per Share

THOMSON REUTERS
·
Aug 14

Zentalis Pharma Falls After Starting Stock Offering

Reuters
·
Aug 14

Zentalis Pharmaceuticals Launches Underwritten Public Offering of Common Stock, Pre-Funded Warrants

Reuters
·
Aug 14

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

THOMSON REUTERS
·
Aug 14

Zentalis price target raised to $5 from $4 at Morgan Stanley

TIPRANKS
·
Aug 07

Gyre Therapeutics Q2 Revenue Beats Estimates on Higher Etuary Sales Volumes

Reuters
·
Aug 07